Official Title
Qualitative Evaluation of Tear Fluid and Blood for IgM and IgG Produced in Response to SARS-CoV2, the Virus Responsible for COVID-19.
Brief Summary

This study objective is to collect tear and blood samples from individuals with positive SARS-COV2 diagnosis and test those samples for the presence of various SARS-COV2 viral antigens and autoantibodies.

Status
Completed
Conditions
SARS-CoV 2 Infection
COVID19
Interventions

Diagnostic Test: SARS-CoV2 Autoantibody detection

Through the data collected from this study we hope to support the development of an ELISA assay for the detection of IgM and IgG autoantibodies produced in response to the presence of SARS-CoV2

Eligibility Criteria

Inclusion Criteria:

- 18 years of age or older Has been tested for SARS-CoV2 and awaiting results Sample
collection for SARS-CoV2 testing Tested positive for SARS-CoV2 virus (confirmed by
RT-PCR) prior to enrollment

Exclusion Criteria:

- Under 18 years of age Concurrent eye infection or trauma unrelated to presence of
SARS-CoV2 virus. Advanced COVID-19 state what would preclude safe and feasible sample
collection.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 100 Years
Countries
United States
Locations

Namida Lab
Fayetteville, Arkansas, United States

Sponsors / Collaborators
Namida Lab
NCT Number
NCT04542980
MeSH Terms
COVID-19
Autoantibodies